Endologix to Hold 2009 First Quarter Financial Results Conference Call on April 23
April 13 2009 - 4:00AM
Business Wire
Endologix, Inc. (Nasdaq:ELGX), the developer of the
Powerlink� System for the minimally invasive treatment of abdominal
aortic aneurysms (AAA), today announced that the Company will hold
a conference call to discuss 2009 first quarter financial results
on Thursday, April 23, 2009 at 5:00 p.m. Eastern time (2:00 p.m.
Pacific time).
Individuals interested in listening to the live conference call
may do so by dialing (888) 463-4487 toll free within the U.S. and
Canada, or (706) 634-5615 for international callers. A telephone
replay of the conference call will be available for 48 hours within
two hours after the conclusion of the call, by dialing (800)
642-1687 domestically or (706) 645-9291 internationally, and
entering reservation number 92665041.
The conference call can be heard live via audio webcast at the
Company�s Web site: www.endologix.com. Please go to the Investor
Relations section of the Web site. A replay will also be available
for 14 days.
About Endologix
Endologix, Inc. develops and manufactures innovative minimally
invasive treatments for aortic disorders. Endologix's Powerlink
System is an endoluminal stent graft for treating abdominal aortic
aneurysms (AAA). AAA is a weakening of the wall of the aorta, the
largest artery in the body, resulting in a balloon-like
enlargement. Once AAA develops, it continues to enlarge and, if
left untreated, becomes increasingly susceptible to rupture. The
overall patient mortality rate for ruptured AAA is approximately
75%, making it a leading cause of death in the U.S. Additional
information can be found on Endologix�s Web site at
www.endologix.com.
Endologix (NASDAQ:ELGX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Endologix (NASDAQ:ELGX)
Historical Stock Chart
From Jul 2023 to Jul 2024